Chemical Cocktails Produce Neurons

Two research groups have devised small-molecule recipes to directly transform fibroblasts into neurons.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

COURTESY OF HONGKUI DENGOver the past several years, scientists have been in hot pursuit of finding an efficient way to directly transform skin cells to brain cells—skipping an intermediate pluripotent step. Genetic approaches have worked to varying degrees. Now, two independent groups report having made the process even simpler, by soaking fibroblasts in combinations of small molecules, thereby obviating the need to tinker with gene expression to turn the cells into neurons.

“These two studies really show that if you just manipulate intercellular signaling pathways, cell fate can be changed,” said Chun-Li Zhang, a neuroscientist at the University of Texas Southwestern Medical Center, who did not participate in the research.

“The inducing efficiency of our approach is comparable with using transgenic reprogramming factors,” HongKui Deng, a cell biologist at Peking University who led one of the teams, told The Scientist in an email. “I hope in the future the chemical approaches would be more robust in inducing functional mature neurons.”

The first direct conversion of a somatic cell to a neuron, by means of inducing particular genes, was reported in 2010 by Marius Wernig’s group at Stanford University. Since then, numerous studies have shown it to be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies